NCT06309966
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
BHVN — Biohaven Ltd.
Phase 2, Phase 3
• Focal Epilepsy
TL;DR
Locations updated — PHASE2, PHASE3
What changed
Recent events (last 90 days)
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.